Gene · 2207
Papers2,891
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,891
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions. | Front Immunol | 2023 | 38045702 | PubTator, text mining | PubMed |
| Single-cell analysis unveils activation of mast cells in colorectal cancer microenvironment. | Cell Biosci | 2023 | 38031173 | PubTator, text mining | PubMed |
| Human leukocyte immunoglobulin-like receptors in health and disease. | Front Immunol | 2023 | 38022598 | PubTator, text mining | PubMed |
| Comprehensive analyses for the coagulation and macrophage-related genes to reveal their joint roles in the prognosis and immunotherapy of lung adenocarcinoma patients. | Front Immunol | 2023 | 38022584 | PubTator, text mining | PubMed |
| Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use? | Transpl Int | 2023 | 38020746 | PubTator, text mining | PubMed |
| A novel tumor purity and immune infiltration-related model for predicting distant metastasis-free survival in prostate cancer. | Eur J Med Res | 2023 | 38017548 | PubTator, text mining | PubMed |
| The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors. | Biomark Res | 2023 | 38017494 | PubTator, text mining | PubMed |
| Single cell and spatial transcriptomics analysis of kidney double negative T lymphocytes in normal and ischemic mouse kidneys. | Sci Rep | 2023 | 38017015 | PubTator, text mining | PubMed |
| Exploiting innate immunity for cancer immunotherapy. | Mol Cancer | 2023 | 38008741 | PubTator, text mining | PubMed |
| The Promotion of Humoral Immune Responses in Humans via SOCS1-Mediated Th2-Bias Following SARS-CoV-2 Vaccination. | Vaccines (Basel) | 2023 | 38006062 | PubTator, text mining | PubMed |
| Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers. | Biomark Res | 2023 | 37981718 | PubTator, text mining | PubMed |
| The Vγ4/butyrophilin conspiracy: novel role of intraepithelial γδ T cells in chronic inflammatory bowel disease. | Signal Transduct Target Ther | 2023 | 37980330 | PubTator, text mining | PubMed |
| Genes associated with inflammation for prognosis prediction for clear cell renal cell carcinoma: a multi-database analysis. | Transl Cancer Res | 2023 | 37969384 | PubTator, text mining | PubMed |
| Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells. | Front Immunol | 2023 | 37965326 | PubTator, text mining | PubMed |
| Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma. | Discov Oncol | 2023 | 37957420 | PubTator, text mining | PubMed |
| Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering. | Nat Commun | 2023 | 37938576 | PubTator, text mining | PubMed |
| Material matters: exploring the interplay between natural biomaterials and host immune system. | Front Immunol | 2023 | 37936689 | PubTator, text mining | PubMed |
| Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: A prospective study. | Heliyon | 2023 | 37928018 | PubTator, text mining | PubMed |
| Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1. | Sci Rep | 2023 | 37923825 | PubTator, text mining | PubMed |
| Protein Tyrosine Phosphatase CD45 As an Immunity Regulator and a Potential Effector of CAR-T therapy. | Acta Naturae | 2023 | 37908772 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2207/papers?page=11